CI
MDCO

Cowen Inc’s Medicines Co MDCO Stock Holding History

Cowen Inc’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$368K Buy
+10,100
New +$330K 0.03% 215
2017
Q3 		– Sell
-11,000
Closed -$418K – 350
2017
Q2 		$418K Buy
11,000
+6,000
+120% +$267K 0.02% 228
2017
Q1 		$245K Buy
+5,000
New +$228K 0.01% 203

Other funds holding MDCO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Cowen Inc's MDCO Position: Q2 2019 in Review

Cowen Inc opened a new position in Medicines Co (MDCO) in Q2 2019: 10,100 shares worth $368K. The stake represents 0.03% of the portfolio and ranks #215 among its holdings. This is a return to the name: Cowen Inc previously reported a position in MDCO as recently as Q2 2017.

Cowen Inc first reported a position in MDCO in Q1 2017 and has held it in 3 quarters since. The position peaked at $418K in Q2 2017. 228 funds tracked by Wall St. Rank hold MDCO as of Q2 2019.

  • Cowen Inc held 10,100 shares of Medicines Co worth $368K as of Q2 2019.
  • Medicines Co was a new Cowen Inc position in Q2 2019.
  • Medicines Co made up 0.03% of Cowen Inc's portfolio in Q2 2019, its #215 holding.
  • Cowen Inc first reported a position in Medicines Co in Q1 2017 and has held it in 3 quarters since.
  • Cowen Inc's Medicines Co position peaked at $418K in Q2 2017.
  • 228 funds tracked by Wall St. Rank held Medicines Co as of Q2 2019.

Based on Cowen Inc's 13F filing for Q2 2019, filed 14 Aug 2019.